Editas Medicine (EDIT) Debt/EBITDA US GAAP (year values) |
|||||||||
2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
Debt/EBITDA | 3.03 | 3.60 | 3.07 | 1.74 | 1.76 | 1.48 | |||
Changes by years, y/y, % | +2% | +19% | -15% | -43% | +1% | -10.0% |
Editas Medicine. Debt/EBITDA
Editas Medicine. Debt/EBITDA, changes, %
Editas Medicine (EDIT) Debt/EBITDA US GAAP (quarter values) |
||||||||
2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
Debt/EBITDA | 1.64 | 2.07 | 2.02 | 1.76 | 1.48 | 1.48 | ||
Changes by years, y/y, % | -36% | -14% | +0% | -1% | -10% | |||
Changes by quarters, q/q, % | -8% | +26% | -2% | -13% | -16% |